182 related articles for article (PubMed ID: 2601028)
21. [Successful pregnancy after 6 years complete remission in patient with acute myeloblastic leukemia].
Shimazaki C; Oku N; Gotoh H; Inaba T; Murakami S; Oku N; Itoh K; Nakanishi S; Nakagawa M; Fujita N
Rinsho Ketsueki; 1991 Jan; 32(1):71-2. PubMed ID: 2020123
[TBL] [Abstract][Full Text] [Related]
22. Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length.
Ohno R; Kato Y; Nagura E; Murase T; Okumura M; Yamada H; Ogura M; Minami S; Suzuki H; Morishima Y
J Clin Oncol; 1986 Dec; 4(12):1740-7. PubMed ID: 3465875
[TBL] [Abstract][Full Text] [Related]
23. Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group.
Elonen E; Almqvist A; Hänninen A; Jansson SE; Järventie G; Koistinen P; Koivunen E; Lahtinen R; Lehtinen M; Nousiainen T; Pelliniemi TT; Rajamäki A; Remes K; Timonen T; Vilpo J; Volin L; Ruutu T
Leukemia; 1998 Jul; 12(7):1041-8. PubMed ID: 9665188
[TBL] [Abstract][Full Text] [Related]
24. [The continuous-DCMP therapy for acute nonlymphocytic leukemia in elderly patients--comparison with younger patients].
Ito T; Yamamoto K; Kinoshita T; Sugiura I; Saito M; Ono Y; Hayashi K; Nagata K; Kamiya O; Ohara K
Rinsho Ketsueki; 1989 Apr; 30(4):421-8. PubMed ID: 2769965
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of adult acute promyelocytic leukemia during the period of 1974-1982].
Kawashima K; Nagura E; Kato Y; Suzuki H; Morishima Y; Ogura M; Watanabe E; Kodera Y; Ohno R; Sugihara T
Rinsho Ketsueki; 1984 Feb; 25(2):121-8. PubMed ID: 6590879
[No Abstract] [Full Text] [Related]
26. A randomized comparison of modified intermediate-dose Ara-C versus high-dose ara-c in post-remission therapy for acute myeloid leukemia.
Fukushima T; Urasaki Y; Yamaguchi M; Ueda M; Morinaga K; Haba T; Sugiyama T; Nakao S; Origasa H; Umehara H; Ueda T
Anticancer Res; 2012 Feb; 32(2):643-7. PubMed ID: 22287757
[TBL] [Abstract][Full Text] [Related]
27. [Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia].
Ishige K; Takagi T; Oguro M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1475-9. PubMed ID: 6588925
[TBL] [Abstract][Full Text] [Related]
28. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
Löwenberg B; Suciu S; Archimbaud E; Haak H; Stryckmans P; de Cataldo R; Dekker AW; Berneman ZN; Thyss A; van der Lelie J; Sonneveld P; Visani G; Fillet G; Hayat M; Hagemeijer A; Solbu G; Zittoun R
J Clin Oncol; 1998 Mar; 16(3):872-81. PubMed ID: 9508168
[TBL] [Abstract][Full Text] [Related]
29. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
Hansen OP; Pedersen-Bjergaard J; Ellegaard J; Brincker H; Boesen AM; Christensen BE; Drivsholm A; Hippe E; Jans H; Jensen KB
Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
[TBL] [Abstract][Full Text] [Related]
30. Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia.
Nagura E; Kimura K; Yamada K; Ohta K; Maekawa T; Takaku F; Uchino H; Masaoka T; Amaki I; Kawashima K
Cancer Chemother Pharmacol; 1994; 34(1):23-9. PubMed ID: 8174198
[TBL] [Abstract][Full Text] [Related]
31. Results of aggressive chemotherapy for myelodysplastic syndromes.
Dohy H; Kyo T
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1428-34. PubMed ID: 3247817
[No Abstract] [Full Text] [Related]
32. [A case of refractory acute myeloblastic leukemia who achieved partial remission by high dose cytosine arabinoside].
Okamoto S; Ogata H; Yoshida T; Oheda Y; Murase T; Toyama K
Rinsho Ketsueki; 1984 May; 25(5):719-23. PubMed ID: 6590900
[No Abstract] [Full Text] [Related]
33. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
Gahrton G; Tidefelt U; Paul C; Björkholm M; Grimfors G; Hast R; Juliusson G; Järnmark M; Killander A; Kimby E
Leukemia; 1992; 6 Suppl 2():89-91. PubMed ID: 1578953
[No Abstract] [Full Text] [Related]
34. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
[TBL] [Abstract][Full Text] [Related]
35. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
De Astis E; Clavio M; Raiola AM; Ghiso A; Guolo F; Minetto P; Galaverna F; Miglino M; Di Grazia C; Ballerini F; Marani C; Pastori G; Mitscheunig L; Cruciani F; Lovera D; Varaldo R; Ghiggi C; Lemoli RM; Bacigalupo A; Gobbi M
Ann Hematol; 2014 Dec; 93(12):2011-8. PubMed ID: 24989345
[TBL] [Abstract][Full Text] [Related]
36. Association between the secondary colony-plating efficiency of blast progenitors and the remission induction outcome of acute myeloblastic leukemia patients.
Nara N
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1624-9. PubMed ID: 3247826
[No Abstract] [Full Text] [Related]
37. [Treatment results of acute nonlymphocytic leukemia in childhood--Kyushu Yamaguchi Children's Cancer Study Group].
Ikuno Y; Okamura J; Ishii E; Matuzaki A; Ueda K; Eguchi H; Inada H; Nibu K; Koga H; Miyazaki S
Rinsho Ketsueki; 1995 Apr; 36(4):325-33. PubMed ID: 7783338
[TBL] [Abstract][Full Text] [Related]
38. [A case of acute nonlymphocytic leukemia with leukemic cell infiltration to the uterus followed by bone marrow relapse].
Shiga Y; Shichishima T; Aikawa K; Gotoh J; Furukawa T; Yamagiwa A; Ishibashi T; Maruyama Y
Rinsho Ketsueki; 1994 May; 35(5):501-5. PubMed ID: 8028198
[TBL] [Abstract][Full Text] [Related]
39. Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.
Holowiecki J; Grosicki S; Giebel S; Robak T; Kyrcz-Krzemien S; Kuliczkowski K; Skotnicki AB; Hellmann A; Sulek K; Dmoszynska A; Kloczko J; Jedrzejczak WW; Zdziarska B; Warzocha K; Zawilska K; Komarnicki M; Kielbinski M; Piatkowska-Jakubas B; Wierzbowska A; Wach M; Haus O
J Clin Oncol; 2012 Jul; 30(20):2441-8. PubMed ID: 22508825
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of acute myelogenous leukemia in patients more than 80 years old].
Takeyama H; Yamamoto Y; Miyata Y; Yamada H; Watanabe E; Aoki H; Iinuma M
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1089-93. PubMed ID: 9239161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]